Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Leader Anti-Itch Camphor, Menthol .5 g/100g; .5 g/100g Lotion, 212 g — NDC 70000-0546-1 (Billing 70000-0546-01)
by LEADER/Cardinal Helath 110, Inc. · 212 g in 1 BOTTLE, PUMP
This is a package of 212 g of Leader Anti-Itch Camphor, Menthol .5 g/100g; .5 g/100g Lotion from LEADER/Cardinal Helath 110, Inc., marketed since Jan 2020 and currently FDA-listed; retail pharmacies pay about $0.0221 per mL (NADAC). It is this product's only package size.
NDC 70000-0546-01
🏷️ FDA NDC (as labeled)
70000-0546-1
billing pads the package segment with a zero
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 70000-0546-1 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 70000 labeler · 0546 product · 1 package
- Package marketed since
- Jan 21, 2020
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 7000005461 8
- Medicaid fills, this package
- 80 prescriptions in the last four reported quarters
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
70000-0546-1
Product NDC
70000-0546
11-digit billing NDC
70000054601
NCPDP billing unit
ML — per mL (volume)
UNII
5TJD82A1ET, L7T10EIP3A
Application #
M017
SPL Set ID
9ca985c6-5017-0558-e053-2995a90a8202
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2020-01-21
Route
TOPICAL
Dosage form
LOTION
Substance
CAMPHOR (SYNTHETIC); MENTHOL
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
GPI-14
90229902104120
GPI class
Anti-Itch
GCN Seq No
023766
GCN
79831
HICL code
002600
Ingredient (HICL)
Menthol/Camphor
HIC1 code
L
Therapeutic class — broad (HIC1)
Skin/Subcutaneous Tissue
HIC2 code
L6
Therapeutic class — intermediate (HIC2)
Irritants
HIC3 code
L6A
Therapeutic class — specific (HIC3)
Irritants/Counter-Irritants
AHFS code
84:92.00.00
AHFS class
Skin And Mucous Membrane Agents, Misc.
FDB label name
ANTI-ITCH 0.5%-0.5% LOTION
FDB brand name
Anti-Itch
Legend status
O — Over-the-counter (OTC) drug or device
Quick answers
- GSN (GCN sequence number): 023766
- GCN: 79831
- GPI-14 (Medi-Span): 90229902104120
- HICL (First Databank): 002600
- AHFS class code: 84:92.00.00
Why two NDCs?
The FDA registers this code as 70000-0546-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0546-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 8, 2026
Clinical
Label name ANTI-ITCH 0.5%-0.5% LOTION Ingredient Menthol/Camphor
🧪 What is this product?
Leader Anti-Itch Camphor, Menthol is a topical lotion marketed as an over-the-counter monograph drug. It contains camphor and menthol, both of which are typically used as topical counterirritants and cooling agents. These ingredients are commonly included in products meant to provide temporary relief of minor itching and skin irritation when applied to the affected area.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
💬 Questions about Camphor, Menthol?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.022 | — |
| Medicaid paysCMS SDUD · 12 mo | $0.0354 | — |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per mL) — tap or hover for the price & month
▲ Up 12% over the last 20 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file · file of Oct 7, 2026
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · through Q1 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 70000-0546-01 You're viewing this Main listing | 212 g in 1 BOTTLE, PUMP | 2020-01-21 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Rugby Anti-Itch .5 g/100g; .5 g/100g 00536-1268-12 | RUGBY | 212 g | $0.022 | — | Availability likely | — |
| GNP Anti Itch .5 g/100g; .5 g/100g 46122-0573-10 | AMERISOURCEBERGEN | 212 g | $0.022 | — | Availability likely | — |
| Leader Anti-Itch .5 g/100g; .5 g/100gthis 70000-0546-01 | LEADER/Cardinal | 212 g | $0.022 | — | Availability likely | — |
| Walgreen Anti Itch .5 g/100g; .5 g/100g 00363-4262-75 | Walgreens | 212 g | — | — | FDA listed | — |
| Discount Drug Mart Anti-Itch .5 g/100g; .5 g/100g 53943-0262-75 | Discount | 212 g | — | — | FDA listed | — |
| CVS Anti-Itch .5 g/100g; .5 g/100g 69842-0626-75 | CVS | 212 g | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file · file of Oct 7, 2026
Availability & generic status
🏛️
2020
On the market since
Jan 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 6, 2026
- FDA openFDA NDC Directory · synced Oct 8, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerLEADER/Cardinal Helath 110, Inc.
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code70000
First marketedJan 2020
Product typeHuman Otc Drug
More NDCs from LEADER/Cardinal Helath 110, Inc. labeler code 70000
- Leader Medicated Dandruff Anti-Seborrheic Dermatitis, Anti-Dandruff Selenium Sulfide 10 mg/mL Shampoo NDC 70000-0531-1
- Leader Ultra Sheer SPF 100 Sunscreen avobenzone, homosalate, octisalate, octocrylene, oxybenzone 30 mg/mL; 150 mg/mL; 50 mg/mL; 100 mg/mL; 60 mg/mL Lotion NDC 70000-0535-1
- Leader General Protection SPF 30 Sunscreen avobenzone, homosalate, octisalate, octocrylene 30 mg/mL; 100 mg/mL; 50 mg/mL; 100 mg/mL Lotion NDC 70000-0536-1
- Gentle Laxative Bisacodyl 5 mg Tablet NDC 70000-0538-1
- Leader Athletes Foot Clotrimazole .01 g/g Cream NDC 70000-0542-1
- Leader Hydrocortisone with Aloe .01 g/g Cream NDC 70000-0543-1
- Leader Bacitracin Zinc 500 [USP'U]/g Ointment NDC 70000-0547-1
- Leader Capsaicin Pain Relief Cream .1 g/100g Cream NDC 70000-0549-1
- Leader Therapeutic Dandruff Anti-Dandruff, anti-seborrheic dematitis and anti-psoriasis Salicylic Acid 30 mg/mL Shampoo NDC 70000-0550-1
- Diclofenac sodium 10 mg/g Gel NDC 70000-0555-1
- Capsaicin Hot Patches .025 g/100g Patch NDC 70000-0556-1
- Leader PAIN RELIEF PATCHES LIDOCAINE 4 g/100g Patch NDC 70000-0557-1
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Ask a Doctor Before Use If
📄 When Using This Product
📄 Stop Use and Ask a Doctor If
📄 Keep Out of Reach of Children
📄 Recent Major Changes
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
temporary relieves pain and itching due to: insect bites minor burns sunburn minor skin irritations minor cuts scrapes rashes due to poison ivy, poison oak, and poison sumac
⏱️ Dosage and Administration ▾
Directions to open, squeeze cap tightly and turn pump counter-clockwise adults and children 2 years and older: apply to affected area not more than 3 to 4 times daily children under 2 years: ask a doctor
⚠️ Warnings ▾
For external use only on chicken pox on measles do not get into eyes condition worsens symptoms last more than 7 days or clear up and occur again within a few days If swallowed, get medical help or contact a Poison Control Center right away.
📦 Storage and Handling ▾
Other information store at 20 °C to 25 °C (68 °F to 77 °F)
🧪 Active Ingredient ▾
Camphor 0.5% Menthol 0.5%
🧪 Inactive Ingredients ▾
carbomer interpolymer type A, cetyl alcohol, DMDM hydantoin, fragrance, glyceryl stearate, isopropyl myristate, PEG-40 stearate, PEG-100 stearate, purified water, sodium hydroxide, stearic acid, white petrolatum
🎯 Purpose ▾
Anti-itch External Analgesic
📄 Ask a Doctor Before Use If ▾
on chicken pox on measles
📄 When Using This Product ▾
do not get into eyes
📄 Stop Use and Ask a Doctor If ▾
condition worsens symptoms last more than 7 days or clear up and occur again within a few days
📄 Keep Out of Reach of Children ▾
If swallowed, get medical help or contact a Poison Control Center right away.
📄 Recent Major Changes ▾
Update to version number to the most recent label with updated inactive ingredient list Updated Titles to remove repeats of Section Type
📄 Package Label / Principal Display Panel ▾
Compare to Sarna Original Anti-Itch lotion Original Formula Anti-Itch Lotion Camphor 0.5% Menthol 0.5% Steroid Free Relief from itching associated with dry skin, insectr bites, poison ivy and Sunburn Cools and Soothes Principal Display Panel 65-262-75v2.2 Back Label
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
80
Units reimbursed last 4 qtrs
17.8K
Gross reimbursed last 4 qtrs
$629.43
Avg / prescription
$7.87
Avg / unit
$0.0354
Latest quarter Q1 2026
17Rx
Medicaid pays / mL
$0.0354
gross reimbursed
vs
NADAC / mL
$0.0221
acquisition cost
=
Spread
+$0.0133
+60% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 0 Rx Managed care · 80 Rx
State Medicaid map
Units reimbursed · per 100k residents
26.3267
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.